About Intelgenx Technologies (CVE:IGX)
IntelGenx Technologies Corp., a drug delivery company, develops novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers RIZAPORT, an oral thin film formulation of rizatriptan benzoate for the treatment of acute migraines. The companys products under development comprise INT0001/2004, an anti-hypertension drug; INT0004/2006, an antidepressant; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid dependence; INT0036/2012 for schizophrenia; and INT0043/2015 to treat mild cognitive impairment and Alzheimers disease. It is also developing various products, including INT0037/2013, INT0039/2013, INT0040/2014, INT0041/2015, INT0042/2015, and INT0044/2016 based on three delivery platform technologies, which consist of VersaFilm, an oral film technology; VersaTab, a multilayer tablet technology; and AdVersa, a mucoadhesive tablet technology. The company has co-development and commercialization agreements with RedHill Biopharma Ltd.; Par Pharmaceutical Companies, Inc.; and Endo Ventures Ltd., as well as a licensing, development, and supply agreement with Chemo Group. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Saint-Laurent, Canada.
Industry, Sector and Symbol
Trailing P/E Ratio-31.6666666666667
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Intelgenx Technologies (CVE:IGX) Frequently Asked Questions
What is Intelgenx Technologies' stock symbol?
Intelgenx Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IGX."
How were Intelgenx Technologies' earnings last quarter?
Intelgenx Technologies Corp. (CVE:IGX) released its quarterly earnings data on Thursday, November, 9th. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01). View Intelgenx Technologies' Earnings History.
When will Intelgenx Technologies make its next earnings announcement?
Who are some of Intelgenx Technologies' key competitors?
Some companies that are related to Intelgenx Technologies include Trillium Therapeutics (TRIL), ContraFect (CFRX), Medgenics (GNMX), Concordia International (CXR), Soligenix (SNGX), Windtree Therapeutics (WINT), Mateon Therapeutics (MATN), Affymax (AFFY), Tetralogic Pharmaceuticals (TLOG), Cubist Pharmaceuticals (CBST), Idenix Pharmaceuticals (IDIX) and Onyx Pharmaceuticals (ONXX).
How do I buy Intelgenx Technologies stock?
Shares of Intelgenx Technologies and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Intelgenx Technologies' stock price today?
One share of Intelgenx Technologies stock can currently be purchased for approximately C$0.95.
How big of a company is Intelgenx Technologies?
Intelgenx Technologies has a market capitalization of C$62.98 million.
MarketBeat Community Rating for Intelgenx Technologies (IGX)MarketBeat's community ratings are surveys of what our community members think about Intelgenx Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Intelgenx Technologies (CVE:IGX) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Intelgenx Technologies (CVE:IGX) Earnings History and Estimates Chart
Intelgenx Technologies (CVE IGX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/27/2018|| || || || || || || || |
Intelgenx Technologies (CVE:IGX) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Intelgenx Technologies (CVE:IGX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Intelgenx Technologies (CVE IGX)
No insider trades for this company have been tracked by MarketBeat.com
Intelgenx Technologies (CVE IGX) News Headlines
Intelgenx Technologies (CVE:IGX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Intelgenx Technologies (CVE IGX) Stock Chart for Saturday, January, 20, 2018